2004. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum, 85, 1-334.
ALBERTI, K. G. & ZIMMET, P. Z. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 15, 539-53.
ALTLPARMAK, E., KOKLU, S., YALINKILIC, M., YUKSEL, O., CICEK, B., KAYACETIN, E. & SAHIN, T. 2005. Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol, 11, 3056-9.
ANDRE, P., RAMIERE, C., SCHOLTES, C., CURTIL, C. & LOTTEAU, V. 2011. Role of nuclear receptors in hepatitis B and C infections. Clin Res Hepatol Gastroenterol, 35, 169-75.
ARMSTRONG, G. L., WILLIAMS, I. T., MAGA, U. A., VIALI, S., KUHNERT, W. L. & MCGARVEY, S. T. 2006. Hepatitis C virus infection in Samoa and American Samoa. Am J Trop Med Hyg, 74, 261-2.
ARNESEN, E., HUSEBY, N. E., BRENN, T. & TRY, K. 1986. The Tromso Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scand J Clin Lab Invest, 46, 63-70.
ASSELAH, T., BOYER, N., RIPAULT, M. P., MARTINOT, M. & MARCELLIN, P. 2007. Management of chronic hepatitis C. Minerva Gastroenterol Dietol, 53, 9-23.
BECKER, B. F. 1993. Towards the physiological function of uric acid. Free Radic Biol Med, 14, 615-31.
BILORA, F., RINALDI, R., BOCCIOLETTI, V., PETROBELLI, F. & GIROLAMI, A. 2002. Chronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta. Gastroenterol Clin Biol, 26, 1001-4.
BUTT, A. A., FULTZ, S. L., KWOH, C. K., KELLEY, D., SKANDERSON, M. & JUSTICE, A. C. 2004. Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection. Hepatology, 40, 115-9.
CARROLL, S., COOKE, C. B. & BUTTERLY, R. J. 2000. Metabolic clustering, physical activity and fitness in nonsmoking, middle-aged men. Med Sci Sports Exerc, 32, 2079-86.
CHEN, C. H., YANG, P. M., HUANG, G. T., LEE, H. S., SUNG, J. L. & SHEU, J. C. 2007. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc, 106, 148-55.
CHEN, J. Y., WANG, J. H., LIN, C. Y., CHEN, P. F., TSENG, P. L., CHEN, C. H., CHANG, K. C., TSAI, L. S., CHEN, S. C. & LU, S. N. 2010. Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both hepatitis B and C strains independently. J Gastroenterol Hepatol, 25, 1763-8.
CHEN, L. K., HWANG, S. J., TSAI, S. T., LUO, J. C., LEE, S. D. & CHANG, F. Y. 2003. Glucose intolerance in Chinese patients with chronic hepatitis C. World J Gastroenterol, 9, 505-8.
CHEN, L. K., LIN, M. H., CHEN, Z. J., HWANG, S. J., TSAI, S. T. & CHIOU, S. T. 2006. Metabolic characteristics and insulin resistance of impaired fasting glucose among the middle-aged and elderly Taiwanese. Diabetes Res Clin Pract, 71, 170-6.
CLARKE, B. 1997. Molecular virology of hepatitis C virus. J Gen Virol, 78 ( Pt 10), 2397-410.
CRAMP, M. E., ROSSOL, S., CHOKSHI, S., CARUCCI, P., WILLIAMS, R. & NAOUMOV, N. V. 2000. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology, 118, 346-55.
CUSTER, B., SULLIVAN, S. D., HAZLET, T. K., ILOEJE, U., VEENSTRA, D. L. & KOWDLEY, K. V. 2004. Global epidemiology of hepatitis B virus. J Clin Gastroenterol, 38, S158-68.
DAI, C. Y., CHUANG, W. L., HO, C. K., HSIEH, M. Y., HUANG, J. F., LEE, L. P., HOU, N. J., LIN, Z. Y., CHEN, S. C., WANG, L. Y., TSAI, J. F., CHANG, W. Y. & YU, M. L. 2008. Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J Hepatol, 49, 9-16.
DOMITROVICH, A. M., FELMLEE, D. J. & SIDDIQUI, A. 2005. Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion. J Biol Chem, 280, 39802-8.
DRAZNIN, B. 2006. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes, 55, 2392-7.
DURANTE-MANGONI, E., ZAMPINO, R., MARRONE, A., TRIPODI, M. F., RINALDI, L., RESTIVO, L., CIOFFI, M., RUGGIERO, G. & ADINOLFI, L. E. 2006. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients. Aliment Pharmacol Ther, 24, 1349-57.
EDWARDS, P. A., KAST, H. R. & ANISFELD, A. M. 2002. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res, 43, 2-12.
FABRIS, C., FEDERICO, E., SOARDO, G., FALLETI, E. & PIRISI, M. 1997. Blood lipids of patients with chronic hepatitis: differences related to viral etiology. Clin Chim Acta, 261, 159-65.
FACCHINI, F., CHEN, Y. D. & REAVEN, G. M. 1994. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care, 17, 115-9.
FANG, J. & ALDERMAN, M. H. 2000. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA, 283, 2404-10.
FARTOUX, L., POUJOL-ROBERT, A., GUECHOT, J., WENDUM, D., POUPON, R. & SERFATY, L. 2005. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut, 54, 1003-8.
FORD, E. S., GILES, W. H. & DIETZ, W. H. 2002. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA, 287, 356-9.
FRIEDMAN, S. L. 1993. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med, 328, 1828-35.
GAMI, A. S., WITT, B. J., HOWARD, D. E., ERWIN, P. J., GAMI, L. A., SOMERS, V. K. & MONTORI, V. M. 2007. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol, 49, 403-14.
GASTAMINZA, P., CHENG, G., WIELAND, S., ZHONG, J., LIAO, W. & CHISARI, F. V. 2008. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol, 82, 2120-9.
GIBONEY, P. T. 2005. Mildly elevated liver transaminase levels in the asymptomatic patient. Am Fam Physician, 71, 1105-10.
GIRAL, P., RATZIU, V. & CHAPMAN, J. C. 2006. Letter regarding article by Ruttmann et al, "gamma-Glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults". Circulation, 113, e299; author reply e299-300.
GORDON, A., MCLEAN, C. A., PEDERSEN, J. S., BAILEY, M. J. & ROBERTS, S. K. 2005. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol, 43, 38-44.
GRIMBERT, S., VALENSI, P., LEVY-MARCHAL, C., PERRET, G., RICHARDET, J. P., RAFFOUX, C., TRINCHET, J. C. & BEAUGRAND, M. 1996. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol, 20, 544-8.
HAIRE-JOSHU, D., GLASGOW, R. E. & TIBBS, T. L. 1999. Smoking and diabetes. Diabetes Care, 22, 1887-98.
HIDVEGI, T., HETYESI, K., BIRO, L. & JERMENDY, G. 2001. Education level and clustering of clinical characteristics of metabolic syndrome. Diabetes Care, 24, 2013-5.
HOU, J., LIU, Z. & GU, F. 2005. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci, 2, 50-57.
HSIEH, H. F., CHEN, T. W., YU, C. Y., WANG, N. C., CHU, H. C., SHIH, M. L., YU, J. C. & HSIEH, C. B. 2008. Aggressive hepatic resection for patients with pyogenic liver abscess and APACHE II score > or =15. Am J Surg, 196, 346-50.
HUANG, J. F., CHUANG, W. L., YU, M. L., YU, S. H., HUANG, C. F., HUANG, C. I., YEH, M. L., HSIEH, M. H., YANG, J. F., LIN, Z. Y., CHEN, S. C., DAI, C. Y. & CHANG, W. Y. 2009. Hepatitis C virus infection and metabolic syndrome---a community-based study in an endemic area of Taiwan. Kaohsiung J Med Sci, 25, 299-305.
HUANG, J. F., DAI, C. Y., HWANG, S. J., HO, C. K., HSIAO, P. J., HSIEH, M. Y., LEE, L. P., LIN, Z. Y., CHEN, S. C., WANG, L. Y., SHIN, S. J., CHANG, W. Y., CHUANG, W. L. & YU, M. L. 2007. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Am J Gastroenterol, 102, 1237-43.
HUI, J. M., SUD, A., FARRELL, G. C., BANDARA, P., BYTH, K., KENCH, J. G., MCCAUGHAN, G. W. & GEORGE, J. 2003. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology, 125, 1695-704.
ISHIZAKA, N., ISHIZAKA, Y., TAKAHASHI, E., TODA EI, E., HASHIMOTO, H., OHNO, M., NAGAI, R. & YAMAKADO, M. 2002. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation, 105, 1028-30.
ISOMAA, B., ALMGREN, P., TUOMI, T., FORSEN, B., LAHTI, K., NISSEN, M., TASKINEN, M. R. & GROOP, L. 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24, 683-9.
JAN, C. F., CHEN, C. J., CHIU, Y. H., CHEN, L. S., WU, H. M., HUANG, C. C., YEN, M. F. & CHEN, T. H. 2006. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Int J Obes (Lond), 30, 794-9.
KAO, J. H. & CHEN, D. S. 2002. Global control of hepatitis B virus infection. Lancet Infect Dis, 2, 395-403.
KAO, J. H., WU, N. H., CHEN, P. J., LAI, M. Y. & CHEN, D. S. 2000. Hepatitis B genotypes and the response to interferon therapy. J Hepatol, 33, 998-1002.
KAPLAN, N. M. 1989. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med, 149, 1514-20.
KAWAGUCHI, T., YOSHIDA, T., HARADA, M., HISAMOTO, T., NAGAO, Y., IDE, T., TANIGUCHI, E., KUMEMURA, H., HANADA, S., MAEYAMA, M., BABA, S., KOGA, H., KUMASHIRO, R., UENO, T., OGATA, H., YOSHIMURA, A. & SATA, M. 2004. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol, 165, 1499-508.
KIECHL, S., EGGER, G., MAYR, M., WIEDERMANN, C. J., BONORA, E., OBERHOLLENZER, F., MUGGEO, M., XU, Q., WICK, G., POEWE, W. & WILLEIT, J. 2001. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation, 103, 1064-70.
KILIC, T., ONER, G., URAL, E., YUMUK, Z., SAHIN, T., BILDIRICI, U., ACAR, E., CELIKYURT, U., KOZDAG, G. & URAL, D. 2009. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome. Atherosclerosis, 207, 552-8.
KIM, H. J., KIM, S. Y., KIM, J., LEE, H., CHOI, M., KIM, J. K. & AHN, J. K. 2008. Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria. IUBMB Life, 60, 473-80.
KIM, K. H., SHIN, H. J., KIM, K., CHOI, H. M., RHEE, S. H., MOON, H. B., KIM, H. H., YANG, U. S., YU, D. Y. & CHEONG, J. 2007. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology, 132, 1955-67.
KNOBLER, H., SCHIHMANTER, R., ZIFRONI, A., FENAKEL, G. & SCHATTNER, A. 2000. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc, 75, 355-9.
KOBAYASHI, Y., KAWAGUCHI, Y., MIZUTA, T., KUWASHIRO, T., OEDA, S., OZA, N., TAKAHASHI, H., IWANE, S., EGUCHI, Y., ANZAI, K., OZAKI, I. & FUJIMOTO, K. 2011. Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C. J Gastroenterol, 46, 529-35.
KOLAK, M., WESTERBACKA, J., VELAGAPUDI, V. R., WAGSATER, D., YETUKURI, L., MAKKONEN, J., RISSANEN, A., HAKKINEN, A. M., LINDELL, M., BERGHOLM, R., HAMSTEN, A., ERIKSSON, P., FISHER, R. M., ORESIC, M. & YKI-JARVINEN, H. 2007. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes, 56, 1960-8.
KUMAR, M., CHOUDHURY, A., MANGLIK, N., HISSAR, S., RASTOGI, A., SAKHUJA, P. & SARIN, S. K. 2009. Insulin resistance in chronic hepatitis B virus infection. Am J Gastroenterol, 104, 76-82.
LAAKSONEN, D. E., LAKKA, H. M., SALONEN, J. T., NISKANEN, L. K., RAURAMAA, R. & LAKKA, T. A. 2002. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care, 25, 1612-8.
LAWLOR, D. A., EBRAHIM, S. & DAVEY SMITH, G. 2002. Socioeconomic position in childhood and adulthood and insulin resistance: cross sectional survey using data from British women's heart and health study. BMJ, 325, 805.
LAZARUS, R., SPARROW, D. & WEISS, S. T. 1997. Alcohol intake and insulin levels. The Normative Aging Study. Am J Epidemiol, 145, 909-16.
LECUBE, A., HERNANDEZ, C., GENESCA, J., ESTEBAN, J. I., JARDI, R. & SIMO, R. 2004. High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. Diabetes Care, 27, 1171-5.
LECUBE, A., HERNANDEZ, C., GENESCA, J. & SIMO, R. 2006a. Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis. Diabetes Care, 29, 1140-9.
LECUBE, A., HERNANDEZ, C., GENESCA, J. & SIMO, R. 2006b. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study. Diabetes Care, 29, 1096-101.
LI, Y., NI, R., SONG, W., SHAO, W., SHRESTHA, S., AHMAD, S., CUNNINGHAM, C. K., FLYNN, P. M., KAPOGIANNIS, B. G., WILSON, C. M. & TANG, J. 2009. Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum Genet, 126, 685-96.
LIESE, A. D., MAYER-DAVIS, E. J. & HAFFNER, S. M. 1998. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev, 20, 157-72.
LUO, B., WANG, Y. & WANG, K. 2007. Association of metabolic syndrome and hepatitis B infection in a Chinese population. Clin Chim Acta, 380, 238-40.
MAGGI, G., BOTTELLI, R., GOLA, D., PERRICONE, G., POSCA, M., ZAVAGLIA, C. & IDEO, G. 1996. Serum cholesterol and chronic hepatitis C. Ital J Gastroenterol, 28, 436-40.
MANNAN, N., BOUCHER, B. J. & EVANS, S. J. 2000. Increased waist size and weight in relation to consumption of Areca catechu (betel-nut); a risk factor for increased glycaemia in Asians in east London. Br J Nutr, 83, 267-75.
MASINI, M., CAMPANI, D., BOGGI, U., MENICAGLI, M., FUNEL, N., POLLERA, M., LUPI, R., DEL GUERRA, S., BUGLIANI, M., TORRI, S., DEL PRATO, S., MOSCA, F., FILIPPONI, F. & MARCHETTI, P. 2005. Hepatitis C virus infection and human pancreatic beta-cell dysfunction. Diabetes Care, 28, 940-1.
MASON, A. L., LAU, J. Y., HOANG, N., QIAN, K., ALEXANDER, G. J., XU, L., GUO, L., JACOB, S., REGENSTEIN, F. G., ZIMMERMAN, R., EVERHART, J. E., WASSERFALL, C., MACLAREN, N. K. & PERRILLO, R. P. 1999. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology, 29, 328-33.
MASON, J. E., STARKE, R. D. & VAN KIRK, J. E. 2010. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol, 13, 36-41.
MCNEILL, A. M., ROSAMOND, W. D., GIRMAN, C. J., GOLDEN, S. H., SCHMIDT, M. I., EAST, H. E., BALLANTYNE, C. M. & HEISS, G. 2005. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care, 28, 385-90.
MEADE, T. W., STIRLING, Y., THOMPSON, S. G., AJDUKIEWICZ, A., BARBARA, J. A. & CHALMERS, D. M. 1987. Carriers of hepatitis B surface antigen: possible association between low levels of clotting factors and protection against ischaemic heart disease. Thromb Res, 45, 709-13.
MEHTA, S. H., BRANCATI, F. L., STRATHDEE, S. A., PANKOW, J. S., NETSKI, D., CORESH, J., SZKLO, M. & THOMAS, D. L. 2003. Hepatitis C virus infection and incident type 2 diabetes. Hepatology, 38, 50-6.
MITCHELL, S. M. & FRAYLING, T. M. 2002. The role of transcription factors in maturity-onset diabetes of the young. Mol Genet Metab, 77, 35-43.
MIYANARI, Y., ATSUZAWA, K., USUDA, N., WATASHI, K., HISHIKI, T., ZAYAS, M., BARTENSCHLAGER, R., WAKITA, T., HIJIKATA, M. & SHIMOTOHNO, K. 2007. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol, 9, 1089-97.
MOHAMMAD ALIZADEH, A. H., FALLAHIAN, F., ALAVIAN, S. M., RANJBAR, M., HEDAYATI, M., RAHIMI, F., KHEDMAT, H., ETEMADI, A., ZALI, M. R. & AZIZI, F. 2006. Insulin resistance in chronic hepatitis B and C. Indian J Gastroenterol, 25, 286-9.
MORRISON, J. A., NAMBOODIRI, K., GREEN, P., MARTIN, J. & GLUECK, C. J. 1983. Familial aggregation of lipids and lipoproteins and early identification of dyslipoproteinemia. The Collaborative Lipid Research Clinics Family Study. JAMA, 250, 1860-8.
MUHLESTEIN, J. B. 2000. Chronic infection and coronary artery disease. Med Clin North Am, 84, 123-48.
MUZZI, A., LEANDRO, G., RUBBIA-BRANDT, L., JAMES, R., KEISER, O., MALINVERNI, R., DUFOUR, J. F., HELBLING, B., HADENGUE, A., GONVERS, J. J., MULLHAUPT, B., CERNY, A., MONDELLI, M. U. & NEGRO, F. 2005. Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol, 42, 41-6.
MYKKANEN, L., KUUSISTO, J., PYORALA, K. & LAAKSO, M. 1993. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia, 36, 553-9.
NAKAGAWA, T., HU, H., ZHARIKOV, S., TUTTLE, K. R., SHORT, R. A., GLUSHAKOVA, O., OUYANG, X., FEIG, D. I., BLOCK, E. R., HERRERA-ACOSTA, J., PATEL, J. M. & JOHNSON, R. J. 2006. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol, 290, F625-31.
NASCIMENTO, M. M., BRUCHFELD, A., SULIMAN, M. E., HAYASHI, S. Y., PECOITS-FILHO, R., MANFRO, R. C., PACHALY, M. A., RENNER, L., STENVINKEL, P., RIELLA, M. C. & LINDHOLM, B. 2005. Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients. Braz J Med Biol Res, 38, 783-8.
NETTLETON, J. A., LUTSEY, P. L., WANG, Y., LIMA, J. A., MICHOS, E. D. & JACOBS, D. R., JR. 2009. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care, 32, 688-94.
NI, Y. H., HUANG, L. M., CHANG, M. H., YEN, C. J., LU, C. Y., YOU, S. L., KAO, J. H., LIN, Y. C., CHEN, H. L., HSU, H. Y. & CHEN, D. S. 2007. Two decades of universal hepatitis B vaccination in Taiwan: Impact and implication for future strategies. Gastroenterology, 132, 1287-1293.
PERRY, I. J., WANNAMETHEE, S. G. & SHAPER, A. G. 1998. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care, 21, 732-7.
PERSICO, M., MASARONE, M., LA MURA, V., PERSICO, E., MOSCHELLA, F., SVELTO, M., BRUNO, S. & TORELLA, R. 2009a. Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities. World J Gastroenterol, 15, 462-6.
PERSICO, M., RUSSO, R., PERSICO, E., SVELTO, M., SPANO, D., ANDOLFO, I., LA MURA, V., CAPASSO, M., TIRIBELLI, C., TORELLA, R. & IOLASCON, A. 2009b. SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells. Clin Chem Lab Med, 47, 1217-25.
POLLEX, R. L. & HEGELE, R. A. 2006. Genetic determinants of the metabolic syndrome. Nat Clin Pract Cardiovasc Med, 3, 482-9.
POYNARD, T., BEDOSSA, P. & OPOLON, P. 1997. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet, 349, 825-32.
PRATI, D., SHIFFMAN, M. L., DIAGO, M., GANE, E., RAJENDER REDDY, K., POCKROS, P., FARCI, P., O'BRIEN, C. B., LARDELLI, P., BLOTNER, S. & ZEUZEM, S. 2006. Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C. J Hepatol, 44, 679-85.
REAVEN, G. M. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37, 1595-607.
REAVEN, G. M. 1994. Syndrome X: 6 years later. J Intern Med Suppl, 736, 13-22.
REINGOLD, J., WANKE, C., KOTLER, D., LEWIS, C., TRACY, R., HEYMSFIELD, S., TIEN, P., BACCHETTI, P., SCHERZER, R., GRUNFELD, C. & SHLIPAK, M. 2008. Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study. J Acquir Immune Defic Syndr, 48, 142-8.
RIDKER, P. M., HENNEKENS, C. H., STAMPFER, M. J. & WANG, F. 1998. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation, 98, 2796-9.
RIDKER, P. M., KUNDSIN, R. B., STAMPFER, M. J., POULIN, S. & HENNEKENS, C. H. 1999. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation, 99, 1161-4.
ROBERTS, K., DUNN, K., JEAN, S. K. & LARDINOIS, C. K. 2000. Syndrome X: medical nutrition therapy. Nutr Rev, 58, 154-60.
ROBINSON, D. & WHITEHEAD, T. P. 1989. Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening. Ann Clin Biochem, 26 ( Pt 5), 393-400.
ROMERO-GOMEZ, M., DEL MAR VILORIA, M., ANDRADE, R. J., SALMERON, J., DIAGO, M., FERNANDEZ-RODRIGUEZ, C. M., CORPAS, R., CRUZ, M., GRANDE, L., VAZQUEZ, L., MUNOZ-DE-RUEDA, P., LOPEZ-SERRANO, P., GILA, A., GUTIERREZ, M. L., PEREZ, C., RUIZ-EXTREMERA, A., SUAREZ, E. & CASTILLO, J. 2005. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology, 128, 636-41.
RUI, L., YUAN, M., FRANTZ, D., SHOELSON, S. & WHITE, M. F. 2002. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem, 277, 42394-8.
SATTAR, N., GAW, A., SCHERBAKOVA, O., FORD, I., O'REILLY, D. S., HAFFNER, S. M., ISLES, C., MACFARLANE, P. W., PACKARD, C. J., COBBE, S. M. & SHEPHERD, J. 2003. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 108, 414-9.
SCHILLACI, G., PIRRO, M., VAUDO, G., GEMELLI, F., MARCHESI, S., PORCELLATI, C. & MANNARINO, E. 2004. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol, 43, 1817-22.
SCHINDHELM, R. K., DEKKER, J. M., NIJPELS, G., BOUTER, L. M., STEHOUWER, C. D., HEINE, R. J. & DIAMANT, M. 2007. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis, 191, 391-6.
SENN, J. J., KLOVER, P. J., NOWAK, I. A., ZIMMERS, T. A., KONIARIS, L. G., FURLANETTO, R. W. & MOONEY, R. A. 2003. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem, 278, 13740-6.
SHAVINSKAYA, A., BOULANT, S., PENIN, F., MCLAUCHLAN, J. & BARTENSCHLAGER, R. 2007. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J Biol Chem, 282, 37158-69.
SIAGRIS, D., CHRISTOFIDOU, M., THEOCHARIS, G. J., PAGONI, N., PAPADIMITRIOU, C., LEKKOU, A., THOMOPOULOS, K., STARAKIS, I., TSAMANDAS, A. C. & LABROPOULOU-KARATZA, C. 2006. Serum lipid pattern in chronic hepatitis C: histological and virological correlations. J Viral Hepat, 13, 56-61.
SIMO, R., HERNANDEZ, C., GENESCA, J., JARDI, R. & MESA, J. 1996. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care, 19, 998-1000.
SINAL, C. J., TOHKIN, M., MIYATA, M., WARD, J. M., LAMBERT, G. & GONZALEZ, F. J. 2000. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell, 102, 731-44.
SU, T. C., LEE, Y. T., CHENG, T. J., CHIEN, H. P. & WANG, J. D. 2004. Chronic hepatitis B virus infection and dyslipidemia. J Formos Med Assoc, 103, 286-91.
SUNG, J., SONG, Y. M., CHOI, Y. H., EBRAHIM, S. & DAVEY SMITH, G. 2007. Hepatitis B virus seropositivity and the risk of stroke and myocardial infarction. Stroke, 38, 1436-41.
THULUVATH, P. J. & JOHN, P. R. 2003. Association between hepatitis C, diabetes mellitus, and race. a case-control study. Am J Gastroenterol, 98, 438-41.
TONG, D. Y., WANG, X. H., XU, C. F., YANG, Y. Z. & XIONG, S. D. 2005. Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol, 11, 1292-6.
TREVISAN, M., LIU, J., BAHSAS, F. B. & MENOTTI, A. 1998. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol, 148, 958-66.
TSOCHATZIS, E., PAPATHEODORIDIS, G. V., MANESIS, E. K., KAFIRI, G., TINIAKOS, D. G. & ARCHIMANDRITIS, A. J. 2008. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis. Aliment Pharmacol Ther, 27, 80-9.
TSUI, J. I., WHOOLEY, M. A., MONTO, A., SEAL, K., TIEN, P. C. & SHLIPAK, M. 2009. Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study. J Card Fail, 15, 451-6.
TUNG, T. H., CHIU, Y. H., CHEN, L. S., WU, H. M., BOUCHER, B. J. & CHEN, T. H. 2004. A population-based study of the association between areca nut chewing and type 2 diabetes mellitus in men (Keelung Community-based Integrated Screening programme No. 2). Diabetologia, 47, 1776-81.
UEKI, K., KADOWAKI, T. & KAHN, C. R. 2005. Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome. Hepatol Res, 33, 185-92.
UEKI, K., KONDO, T., TSENG, Y. H. & KAHN, C. R. 2004. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci U S A, 101, 10422-7.
VAN DAM, R. M., RIMM, E. B., WILLETT, W. C., STAMPFER, M. J. & HU, F. B. 2002. Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med, 136, 201-9.
VAN DER POORTEN, D., KENNY, D. T., BUTLER, T. & GEORGE, J. 2007. Liver disease in adolescents: A cohort study of high-risk individuals. Hepatology, 46, 1750-8.
VISNEGARWALA, F., CHEN, L., RAGHAVAN, S. & TEDALDI, E. 2005. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection. J Infect, 50, 331-7.
VOLZKE, H., SCHWAHN, C., WOLFF, B., MENTEL, R., ROBINSON, D. M., KLEINE, V., FELIX, S. B. & JOHN, U. 2004. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis, 174, 99-103.
VOZAROVA, B., STEFAN, N., LINDSAY, R. S., SAREMI, A., PRATLEY, R. E., BOGARDUS, C. & TATARANNI, P. A. 2002. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes, 51, 1889-95.
WANG, C. C., HSU, C. S., LIU, C. J., KAO, J. H. & CHEN, D. S. 2008. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol, 23, 779-82.
WANG, C. S., WANG, S. T., YAO, W. J., CHANG, T. T. & CHOU, P. 2003. Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status. Am J Epidemiol, 158, 1154-60.
WANG, L. Y., HU, C. T., HO, T. Y. & LIN, H. H. 2006. Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area. Vaccine, 24, 4427-32.
WANLESS, I. R., WONG, F., BLENDIS, L. M., GREIG, P., HEATHCOTE, E. J. & LEVY, G. 1995. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology, 21, 1238-47.
WANNAMETHEE, G., EBRAHIM, S. & SHAPER, A. G. 1995. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol, 142, 699-708.
WARIS, G., FELMLEE, D. J., NEGRO, F. & SIDDIQUI, A. 2007. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol, 81, 8122-30.
WASLEY, A. & ALTER, M. J. 2000. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis, 20, 1-16.
WESTERBACKA, J., LAMMI, K., HAKKINEN, A. M., RISSANEN, A., SALMINEN, I., ARO, A. & YKI-JARVINEN, H. 2005. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab, 90, 2804-9.
WILSON, P. W., D'AGOSTINO, R. B., PARISE, H., SULLIVAN, L. & MEIGS, J. B. 2005. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation, 112, 3066-72.
WONG, G. L., WONG, V. W., CHOI, P. C., CHAN, A. W., CHIM, A. M., YIU, K. K., CHAN, H. Y., CHAN, F. K., SUNG, J. J. & CHAN, H. L. 2009. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut, 58, 111-7.
WU, S. H., LIU, Z. & HO, S. C. Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. Eur J Epidemiol, 25, 375-84.
YELKEN, B., GORGULU, N., CALISKAN, Y., ELITOK, A., CIMEN, A. O., YAZICI, H., OFLAZ, H., TURKMEN, A. & SEVER, M. S. 2009. Association between chronic hepatitis C infection and coronary flow reserve in dialysis patients with failed renal allografts. Transplant Proc, 41, 1519-23.
YEN, A. M., CHIU, Y. H., CHEN, L. S., WU, H. M., HUANG, C. C., BOUCHER, B. J. & CHEN, T. H. 2006. A population-based study of the association between betel-quid chewing and the metabolic syndrome in men. Am J Clin Nutr, 83, 1153-60.
YEN, S. L., CHIU, T. Y., LIN, Y. C., LEE, Y. C., LEE, L. T. & HUANG, K. C. 2008. Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen. Int J Obes (Lond), 32, 474-80.
YEN, T., KEEFFE, E. B. & AHMED, A. 2003. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol, 36, 47-53.
行政院疾病管制局 http://www.cdc.gov.tw/public/Attachment/8791601971.pdf
行政院衛生署統計資料 http://www.doh.gov.tw/statistic/data
賴世偉、黃金財、李佳霙（2004）．健檢民眾B型及C型肝炎盛行率之描述分
析：以某醫學中心為例．中台灣醫誌
李佩倫、王景弘、盧勝男、郭秀玲（2003）．C型肝炎感染是否會增加糖尿病發生的機會：C型肝炎盛行社區之斷面研究．內科學誌，14（2），58-61。陳建仁等，台灣地區高血壓、高血糖、高血脂盛行率調查報告，行政院衛生署國民健康局，2003。
陳建仁等，台灣地區高血壓、高血糖、高血脂追蹤調查報告。行政院衛生署國民
健康局委辦, 2008。
行政院衛生署NAHSIT 2005-2008 http://nahsit.nhri.org.tw/node/21。
行政院疾病管制局http://www.cdc.gov.tw/public/Attachment/8791782771.pdf。
楊孔嘉、張定宗等， C 型肝炎病毒-脂質顆粒的蛋白質體與感染性特定分析，
2008。